Padagis US LLC has recalled 7,032 bottles of Trospium Chloride Extended-Release Capsules (60 mg), a prescription medication used to treat overactive bladder. The recall was issued because some bottles may contain missing, broken, or extra tablets within the capsules, which could lead to incorrect dosing. The affected products were distributed nationwide in 30-count bottles under the NDC number 0574-0118-30.
A defect in the number or condition of tablets within a capsule can result in a patient receiving too much or too little medication. This could cause the treatment to be ineffective or increase the risk of adverse side effects associated with the drug.
You have 2 options:
Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Distributed By: Padagis.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.